Characteristics | CD68 expression in TMA-2020 NO.1-8 | Total (n = 321) | P-value | |
---|---|---|---|---|
High expression (n = 238) | Low expression (n = 83) | |||
Age | Â | Â | Â | 0.4993 |
  <60 years | 142 | 46 | 188 |  |
  ≥60 years | 96 | 37 | 133 |  |
Sex | Â | Â | Â | 0.0914 |
  Male | 160 | 64 | 224 |  |
  Female | 78 | 19 | 97 |  |
Fuhrman grade | Â | Â | Â | <0.0001 |
  1–2 | 207 | 54 | 261 |  |
  3–4 | 31 | 29 | 60 |  |
TNM stage | Â | Â | Â | 0.0024 |
  I–II | 213 | 62 | 275 |  |
  III–IV | 24 | 21 | 45 |  |
  NA | 1 | 0 | 1 |  |
T category | Â | Â | Â | 0.0117 |
  T1a–T1b | 196 | 56 | 252 |  |
  T2a–T4 | 41 | 27 | 68 |  |
  NA | 1 | 0 | 1 |  |
Overall survival | Â | Â | Â | 0.0282 |
  − | 191 | 58 | 249 |  |
  + | 9 | 8 | 17 |  |
  NA | 38 | 17 | 55 |  |
Progression-free survival | Â | Â | <0.0001 | |
  − | 186 | 49 |  |  |
  + | 14 | 16 |  |  |
  NA | 38 | 17 | 55 |  |